We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

64 hedge funds and large institutions have $616M invested in Solid Biosciences in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

420% more capital invested

Capital invested by funds: $119M → $616M (+$498M)

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

83% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 12

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

10% more funds holding

Funds holding: 58 → 64 (+6)

0.15% more ownership

Funds ownership: 3.11% → 3.26% (+0.15%)

Holders
64
Holders Change
+6
Holders Change %
+10.34%
% of All Funds
1.47%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
20
Increased
22
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$41.6M
2
PHS
PFM Health Sciences
California
+$9.63M
3
AC
Armistice Capital
New York
+$3.69M
4
DM
Deerfield Management
New York
+$3.68M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.47M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.15M
2
Millennium Management
Millennium Management
New York
-$5.03M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.98M
4
GTC
Ghost Tree Capital
New York
-$2.89M
5
ACA
Avoro Capital Advisors
New York
-$2.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$2.16M +$1.24M +4,043 New
HCM
27
Highline Capital Management
New York
$1.87M +$1.08M +3,494 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$1.85M +$574K +1,867 +116%
UBS Group
29
UBS Group
Switzerland
$1.44M +$607K +1,973 +274%
Charles Schwab
30
Charles Schwab
California
$1.35M +$54.5K +177 +8%
Hudson Bay Capital Management
31
Hudson Bay Capital Management
Connecticut
$1.25M +$718K +2,333 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.14M +$241K +782 +58%
Millennium Management
33
Millennium Management
New York
$869K -$5.03M -16,357 -91%
Morgan Stanley
34
Morgan Stanley
New York
$776K +$30.2K +98 +7%
TCIM
35
TIAA CREF Investment Management
New York
$713K +$133K +433 +48%
TA
36
Teachers Advisors
New York
$675K +$174K +564 +81%
Deutsche Bank
37
Deutsche Bank
Germany
$639K +$126K +408 +52%
AllianceBernstein
38
AllianceBernstein
Tennessee
$620K +$357K +1,160 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$496K +$2.15K +7 +0.8%
AH
40
Aviva Holdings
Bahamas
$409K +$236K +766 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$374K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$306K +$176K +572 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$263K +$151K +492 New
BC
44
Birchview Capital
Vermont
$214K -$287K -933 -70%
AIG
45
American International Group
New York
$211K +$2.46K +8 +2%
Goldman Sachs
46
Goldman Sachs
New York
$201K +$115K +375 New
Wells Fargo
47
Wells Fargo
California
$155K +$12.3K +40 +16%
PIM
48
Partner Investment Management
California
$134K +$77.2K +251 New
Barclays
49
Barclays
United Kingdom
$104K +$21.5K +70 +56%
SO
50
STRS Ohio
Ohio
$103K +$6.15K +20 +12%
1
2
3 4

SLDB Hedge Fund Activity: Q2 2018 in Review

64 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q2 2018, worth a combined $616M — up 420% from $119M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SLDB positions and 13 closed out — a net gain of 7 holders — while 22 added to existing stakes and 12 trimmed.

The largest buyer was Boxer Capital, adding an estimated $41.6M. The largest seller was Adage Capital Partners, cutting an estimated $6.15M.

  • 64 institutional investors held Solid Biosciences (SLDB) as of Q2 2018, up from 58 in Q1 2018.
  • Funds reported $616M of Solid Biosciences stock for Q2 2018, up 420% quarter-over-quarter.
  • 20 funds opened new Solid Biosciences positions in Q2 2018 and 13 closed out, a net change of +7 holders.
  • The largest Solid Biosciences buyer in Q2 2018 was Boxer Capital, an estimated $41.6M added.
  • The largest Solid Biosciences seller in Q2 2018 was Adage Capital Partners, an estimated $6.15M sold.

Based on aggregated 13F filings for Q2 2018.